This company has been marked as potentially delisted and may not be actively trading. OncoSec Medical (ONCS) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ONCS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period PVCT Provectus Biopharmaceuticals, Inc.August 25, 2024 | seekingalpha.comONCS - OncoSec Medical IncorporatedJune 24, 2023 | finance.yahoo.comWhy Is OncoSec Medical (ONCS) Stock Up 100% Today?June 23, 2023 | markets.businessinsider.comWhy John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionJune 15, 2023 | msn.comWhy Is OncoSec Medical (ONCS) Stock Down 48% Today?June 15, 2023 | msn.comOncoSec Medical (Nasdaq:ONCS) HeadlineTrading was temporarily halted for "ONCS" at 04:06 PM with a stated reason of "News pending."...June 14, 2023 | marketbeat.comOncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMay 18, 2023 | finance.yahoo.comOncoSec Medical plunges 35% lower on sale of 1.4M shares of common stockMay 16, 2023 | msn.comOncoSec Announces $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMay 16, 2023 | finance.yahoo.comOncoSec is encouraged after FDA meeting to discuss proposed neoadjuvant melanoma clinical programMay 16, 2023 | finance.yahoo.comOncoSec Receives $3.49 Million to Strengthen its Balance Sheet After Selling its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Authority NOL ProgramApril 27, 2023 | finance.yahoo.comOncoSec Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesApril 11, 2023 | finance.yahoo.comWhy OncoSec Medical Shares Are Soaring TodayApril 10, 2023 | msn.comOncoSec Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesApril 10, 2023 | finance.yahoo.comOncoSec Medical (Nasdaq:ONCS) HeadlineTrading was temporarily halted for "ONCS" at 11:04 AM with a stated reason of "LULD pause."...April 10, 2023 | marketbeat.comOncoSec Medical Inc (ONCS) is lower by 6.15% Tuesday In Premarket TradingApril 6, 2023 | benzinga.comOncoSec Shares Disappointing Results From Skin Cancer Combo Therapy Trial, Sets Stage For Neoadjuvant Setting StudyApril 3, 2023 | finance.yahoo.comOncoSec crashes ~60% after TAVO-EP, Keytruda combo fails phase 2 skin cancer trialApril 3, 2023 | msn.comOncoSec Announces Clinical Data of the KEYNOTE-695 Trial Assessing TAVO™-EP in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Melanoma Refractory to anti-PD-1 TreatmentApril 3, 2023 | finance.yahoo.comOncoSec Medical Withdraws Planned Offering, Shares Rise Over 50%March 1, 2023 | marketwatch.comWhy is OncoSec Medical (ONCS) Stock Up 91% Today?March 1, 2023 | msn.comONCS.OQ - | Stock Price & Latest News | ReutersJanuary 16, 2023 | reuters.comOncoSec Medical Stock (NASDAQ:ONCS), Quotes and News SummaryJanuary 5, 2023 | benzinga.comPeering Into OncoSec Medical's Recent Short InterestDecember 8, 2022 | msn.comOncoSec to Present at the RHK Capital Disruptive Growth Conference on December 6, 2022December 5, 2022 | finance.yahoo.comOncoSec Shares Drop 25% on Equity Offer Pricing After 51% Tuesday SurgeNovember 30, 2022 | marketwatch.comOncoSec Announces Pricing of $3.5 Million Public OfferingNovember 30, 2022 | finance.yahoo.comOncoSec Touts Encouraging Early Data For Opdivo Combined Immunotherapy For Skin CancerNovember 24, 2022 | finance.yahoo.comOncoSec provides updates on cancer programs in new filingNovember 23, 2022 | seekingalpha.comLooking Into OncoSec Medical's Recent Short InterestNovember 22, 2022 | msn.comOncoSec Medical (Nasdaq:ONCS) HeadlineTrading was temporarily halted for "ONCS" at 03:11 PM with a stated reason of "LULD pause."...November 21, 2022 | marketbeat.comOncoSec Medical (Nasdaq:ONCS) HeadlineTrading was temporarily halted for "ONCS" at 12:11 PM with a stated reason of "LULD pause."...November 21, 2022 | marketbeat.comOncoSec presents encouraging early data with TAVO™-EP combined with nivolumab (Opdivo®) in neoadjuvant melanomaNovember 15, 2022 | finance.yahoo.comOncoSec Announces Positive Clinical Data of the KEYNOTE-695 Trial Assessing TAVO-EP in Combination with Pembrolizumab (Keytruda®) in Patients with Advanced Melanoma Refractory to anti-PD-1 TreatmentNovember 11, 2022 | finance.yahoo.comOncoSec Medical Shares Hit New Depths Ahead of Reverse Stock Split >ONCSNovember 8, 2022 | marketwatch.comOncoSec Announces Reverse Stock SplitNovember 8, 2022 | finance.yahoo.comOncoSec Cuts Workforce, Prioritizes PipelineOctober 13, 2022 | finance.yahoo.comOncoSec Medical to Restructure, Cut JobsOctober 4, 2022 | marketwatch.comOncoSec Medical To Reduce Staff By About 45%October 4, 2022 | markets.businessinsider.comOncoSec Announces Pipeline Prioritization and Workforce ReductionOctober 4, 2022 | finance.yahoo.comRobert Arch joins OncoSec Medical as CEOApril 29, 2022 | seekingalpha.comOncoSec Appoints Dr. Robert Arch as President and Chief Executive OfficerApril 29, 2022 | finance.yahoo.comBTIG Maintains Buy on OncoSec Medical, Lowers Price Target to $5March 16, 2022 | benzinga.comOncoSec Medical (NASDAQ:ONCS) PT Lowered to $5.00March 16, 2022 | marketbeat.comOncoSec appoints new finance chiefFebruary 23, 2022 | seekingalpha.comOncoSec Medical Inc Shares Approach 52-Week Low - Market MoverOctober 9, 2021 | nasdaq.comOncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology ConferenceAugust 3, 2021 | finance.yahoo.comOncoSec Medical Incorporated Common Stock (ONCS)July 27, 2021 | nasdaq.com Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ONCS Media Mentions By Week ONCS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONCS News Sentiment▼0.000.93▲Average Medical News Sentiment ONCS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONCS Articles This Week▼00▲ONCS Articles Average Week Get the Latest News and Ratings for ONCS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for OncoSec Medical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 60 Degrees Pharmaceuticals News Alpha Tau Medical News BriaCell Therapeutics News enGene News Fortress Biotech News GeoVax Labs News Jasper Therapeutics News NewAmsterdam Pharma News Nutriband News Reviva Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONCS) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSec Medical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoSec Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
